Objectives: In resectable advanced laryngeal cancer, the locoregional control rate achieved with reduced intraarterial cisplatin and concurrent radiotherapy（Kanazawa regimen）was comparable to that of the concurrent chemoradiotherapy arm of the Radiation Therapy Oncology Group study 91-11 with reduced toxicities. However, distant metastases were more frequent. This study retrospectively evaluated the efficacy and feasibility of adjuvant chemotherapy with TS-1 Ⓡ , an oral fluoropyrimidine, on distant metastases following the Kanazawa regimen.

